At Adicet (Nasdaq: ACET), we are defined by our mission to deliver best-in-class gamma-delta T cell therapies for patients fighting cancer. Every one of our team members, whether in the lab, manufacturing, or general business role, comes to work every day with the patient in mind. As pioneers in the cell therapy space, we are honored and humbled by the opportunity to put our talents to bear in developing transformative therapies to defeat cancer. We believe that the best way to do this is through discovering and developing allogeneic gamma-delta T cell therapies, a novel type of cell therapy. Adicet has chosen the gamma-delta T cell because it has multiple ways to target and kill cancer cells, which may provide a better chance of achieving complete and durable responses to therapy. Additionally, instead of using cells from the already sick cancer patient, Adicet uses cells from unrelated donors (allogeneic) because they are reliable and readily available allowing us to rapidly and cost-effectively scale production of these medicines and make them available when needed (“off-the-shelf”). Specifically, as a clinical stage biotechnology company we are advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors (CAR) and T cell receptor-like antibodies (TCRL) to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients. To learn more or inquire about joining our team in Boston, MA or Redwood City, CA, please visit http://www.adicetbio.com
View Top Employees from Adicet Bio, IncWebsite | http://www.adicetbio.com |
Revenue | $24 million |
Funding | $131 million |
Employees | 157 (157 on RocketReach) |
Founded | 2014 |
Address | 1000 Bridge Pkwy, Redwood City, California 94065, US |
Phone | (650) 542-0034 |
Technologies |
JavaScript,
HTML,
Google Analytics
+27 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Biopharma, Drug Discovery, Healthcare, Health Care, Science and Engineering, Medical |
Web Rank | 4 Million |
Keywords | Cancer Treatment, Biotechnology, Clinical Stage Biotechnology |
Competitors | BIOSENIC S.A., BlueRock Therapeutics, Eureka Therapeutics, Inc, Semma Therapeutics, Tessa Therapeutics Ltd |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies |
Looking for a particular Adicet Bio, Inc employee's phone or email?
The Adicet Bio, Inc annual revenue was $24 million in 2024.
Nick Harvey is the CFO of Adicet Bio, Inc.
157 people are employed at Adicet Bio, Inc.
Adicet Bio, Inc is based in Redwood City, California.
The NAICS codes for Adicet Bio, Inc are [541, 54171, 54, 5417, 541713].
The SIC codes for Adicet Bio, Inc are [87, 873].